Explore more publications!

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on March 25, 2026

Eat, Play, and Relax with Solo Excursions on Florida’s Historic Coast
Eascra Biotech Takes First Place at TechConnect Bio in Space Innovation Challenge
Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers
The ROOT Brands® Introduces CRUSH and SCULPT as a Smart, Non Drug Wellness Path Before, After or During Synthetic GLPs
Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development
SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge
SEMCAP Launches SEMCAP Beauty & Wellness to Capitalize on Opportunities in Burgeoning Longevity and Consumer Wellbeing Space
InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit
VIVUS bekræfter den kliniske effektivitet og sikkerhed af QSIVA® i behandlingen af fedme
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
VIVUS vahvistaa QSIVAn® kliinistä tehoa ja turvallisuutta lihavuuden hallinnassa
VIVUS förstärker budskapet om klinisk effekt och säkerhet för QSIVA® vid behandling av obesitas
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
SafeSpace Global to Attend ISC West 2026 to Strengthen Industry Relationships and Expand Strategic Pipeline
VeonGen Announces Clinical Progress of VG801 Gene Therapy in Stargardt Disease, with an Oral Presentation at ARVO 2026
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Jushi Holdings Inc. Announces First Settlement in Ongoing Hemp-Derived THC Litigation
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions